Search research articles
Contact Us
Filters
Showing results (61-70 of 63) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 63 results.
Nuclear Medicine and Biology
|
August 8, 2025
Characterization of [<sup>11</sup>C]DASB and [<sup>18</sup>F]FE-PE2I using microPET imaging in SERT and DAT knockout rats
Cyprien G J Guerrin, Debbie R M Tesselaar, Emile E Zweistra, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial
M Hayat, G Brulé, P Cappelaere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration
J L Misset, M di Palma, M Delgado, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 63) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 63 results.
Nuclear Medicine and Biology
|
August 8, 2025
Characterization of [<sup>11</sup>C]DASB and [<sup>18</sup>F]FE-PE2I using microPET imaging in SERT and DAT knockout rats
Cyprien G J Guerrin, Debbie R M Tesselaar, Emile E Zweistra, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial
M Hayat, G Brulé, P Cappelaere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration
J L Misset, M di Palma, M Delgado, et al.
Page
of 7